Dr Candice Z Ulmer Holland Ph.D.

Dr. Candice Z. Ulmer holds BS degrees in Chemistry and Biochemistry from the College of Charleston. She obtained her Ph.D. in Chemistry at the University of Florida in 2016 under the direction of Dr. Richard Yost after only a 4-year tenure. Her multi-omics doctoral research focused on two main applications, T cell immune dysregulation in Type 1 Diabetes and biomarker discovery in melanoma skin cancer. After receiving her doctorate, Dr. Ulmer immediate pursued a NRC post-doctoral research fellowship at NIST under the direction of Dr. John Bowden, where her work focused on the standardization of lipid measurements in the first international lipidomics interlaboratory exercise. Dr. Candice Z. Ulmer is currently a Clinical Chemist at the Centers for Disease Control and Prevention in Atlanta, GA. As Project Lead and Acting Chief of the Clinical Reference Laboratory for Cancer, Kidney, and Bone Disease Biomarkers in the Clinical Chemistry Branch, Dr. Ulmer is involved with the planning and execution of programs to ensure the accurate measurement of chronic disease biomarkers (e.g., steroid and protein hormones) and the assessment of clinical analytical methods in patient care, both internationally and domestically. Dr. Ulmer was nominated by the American Association of Clinical Chemistry (AACC) to serve on the newly-formed International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Bone Metabolism. She is a co-chair of the American Society for Mass Spectrometry (ASMS) clinical chemistry interest group and publication committee. With over 30 publications and a pending patent as an early-career chemist, she serves as the ASMS clinical chemistry interest group co-chair and assumes appointed/elected memberships in six committees for other scientific organizations that include the International Metabolomics Society, the Metabolomics Quality Assurance and Quality Control Consortium, Metabolomics of North America, and the American Chemical Society.